Horsham: Johnson & Johnson has announced that the Company ahs received approval from the U.S. Food and Drug Administration ...

New magnetic nanoparticles in the shape of a cube sandwiched between two pyramids represent a breakthrough for treating ovarian tumors and possibly other types of cancer.

Almost half of children who require surgery for complicated appendicitis can safely complete their recovery at home, according to a new study.

Johnson & Johnson announced that the FDA has approved TREMFYA, or guselkumab, the first and only IL-23 inhibitor offering ...

Celltrion announced the commercial launch of STEQEYMA® (ustekinumab-stba), a biosimilar of Janssen’s STELARA® (ustekinumab), in the United States. As we previously reported, the biosimilar was ...

Almost half of children who require surgery for complicated appendicitis can safely complete their recovery at home, ...

The Florida Department of Health report stated that three people were infected "very rare strain of the disease." ...

In Vitro studies have shown promise against viruses similar to the bird flu virus. BOSTON, MASSACHUSETTS, (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “ ...

The following is a summary of “Incidence of Acute Kidney Injury After Exposure to Intravenous Contrast in Emergency ...

A company promoting an intravenous form of cannabidiol (CBD) has been sent a warning letter from the U.S. Food and Drug ...

Treatment with inebilizumab was associated with continued improvement in patients with AChR+ generalized myasthenia gravis, according to 52-week results from the MINT trial.